Latest Breaking News On - Recent corporate highlights - Page 1 : vimarsana.com

Candel Therapeutics : Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights - Form 8-K -March 28, 2024 at 07:48 am EDT

Candel Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today reported financial results for.

Aljanae reynoldsTheodore jenkinsCandel therapeutics incExchange commissionDevelopment expensesDrug administrationBusiness developmentSociety for immunotherapy of cancerDevelopment service revenueInternational oncolytic virus conferenceCompany nasdaqCandel therapeutics reports fourth quarterFull yearRecent corporate highlightsTrack designationsTrack designation

Mustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Mustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMazyar shadmanManuel litchmanNicole mccloskeyFred hutchJaclyn jaffeUniversity of alabama at birminghamUs committee on foreign investmentAmerican society of hematology annual meetingAmerican society of hematologyAmerican association for cancer researchMustang bio incCompany nasdaqSecurities exchangeFortress biotech incVivo technology platform

Mustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Mustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesJaclyn jaffeMazyar shadmanManuel litchmanFred hutchNicole mccloskeyCompany contactsAmerican association for cancer researchUs committee on foreign investmentMustang bio incFortress biotech incUniversity of washingtonVivo technology platformSecurities exchangeBrigene boston biosciences incUniversity of alabama at birmingham

PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights

PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew jerseyDeepika jalotaArnold levineMarc fellousMasha poyurovskyDavid mackCharles baumHead of clinical developmentPharmaceuticals incHead of corporate developmentMerck co incPharmaceuticals inc balance sheetsMerck sharp dohmeDrug administrationPharmaceuticals inc condensed statements of operations

Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023

-Reported positive results from EMERALD-1 phase 2a trial of MORF-057 in ulcerative colitis - -Enrollment on target in EMERALD-2 phase 2b global randomized trial of MORF-057 in UC- .

Praveen tipirneniChris erdmanMorphic holding incSecurities exchangeExchange commissionGlobenewswire incChief executive officerRecent corporate highlightsRobarts histopathology indexMayo clinic scoreSimple endoscopic scoreFull yearModified mayo clinic scoreDisease activity indexSecurities actSecurities exchange act